Your browser doesn't support javascript.
loading
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization.
Ye, Tong; Jiao, Zhouguang; Li, Xin; He, Zhanlong; Li, Yanyan; Yang, Fengmei; Zhao, Xin; Wang, Youchun; Huang, Weijin; Qin, Meng; Feng, Yingmei; Qiu, Yefeng; Yang, Wenhui; Hu, Lingfei; Hu, Yaling; Zhai, Yu; Wang, Erqiang; Yu, Di; Wang, Shuang; Yue, Hua; Wang, Yishu; Wang, Hengliang; Zhu, Li; Ma, Guanghui; Wei, Wei.
Afiliación
  • Ye T; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
  • Jiao Z; School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, China.
  • Li X; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
  • He Z; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
  • Li Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology, Beijing, China.
  • Yang F; Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Institute of Medical Biology, Peking Union Medical College, Chinese Academy of Medical Sciences, Kunming, China.
  • Zhao X; Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Institute of Medical Biology, Peking Union Medical College, Chinese Academy of Medical Sciences, Kunming, China.
  • Wang Y; Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Institute of Medical Biology, Peking Union Medical College, Chinese Academy of Medical Sciences, Kunming, China.
  • Huang W; Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Institute of Medical Biology, Peking Union Medical College, Chinese Academy of Medical Sciences, Kunming, China.
  • Qin M; Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.
  • Feng Y; Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.
  • Qiu Y; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Yang W; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Hu L; Laboratory Animal Center, Academy of Military Medical Science, Beijing, China.
  • Hu Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Zhai Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Wang E; Sinovac Life Sciences Co., Ltd., Beijing, China.
  • Yu D; Sinovac Life Sciences Co., Ltd., Beijing, China.
  • Wang S; Sinovac Life Sciences Co., Ltd., Beijing, China.
  • Yue H; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Wang Y; Ian Frazer Centre for Children's Immunotherapy Research, Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Wang H; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
  • Zhu L; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
  • Ma G; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
  • Wei W; School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, China.
Nature ; 624(7992): 630-638, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38093012

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Mucosa / Vacunas contra la COVID-19 Límite: Animals / Humans Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Mucosa / Vacunas contra la COVID-19 Límite: Animals / Humans Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido